LIFECODES® C3d Detection Assay
Detect C3d-binding donor specific anti-HLA antibodies (DSAs) for better risk stratification of patients.
Detect C3d-binding donor-specific anti-HLA antibodies (DSAs) for better risk stratification of patients.
The LIFECODES C3d Assay provides a measure of the binding and processing of complement to one of its end products - C3d. When combined with our LIFECODES LSA Single Antigen Kits, the assay offers a simple method for the detection of complement binding to HLA antibodies.
- Identifies complement binding antibodies
- Streamlines work flow with MATCH IT!® Antibody software
- Utilizes highly sensitive Luminex® xMAP® technology
Product offerings may differ by region, please check with your local Werfen representative for regulatory status in your area.
Resource Library
PACKAGE INSERTS (PI/ IFU), SAFETY DATA SHEETS (SDS), CERTIFICATES of ANALYSIS, LOT SPECIFIC FILES, and more can be accessed on our customer center.
Our Certifications
Related Products
- Testimonial
- Transplant
- Customer
The fact that Immucor representatives are former transplant technologists adds one more layer of support for us. I appreciate Immucor's commitment to comprehensive customer support, from assay and software development to technical and educational support. It's a team approach between vendor and customer that is more than a business relationship. It's a joint mission to benefit patients.
Ellen Klohe, PhD, D(ABHI), HLA Laboratory Director, Vitalant Spokane Laboratory, USA
Let's Get Started On Your Story- Testimonial
- Transplant
- Customer
Immucor products enable us to accurately assign HLA antibody specificities for better transplant outcomes!
Sam Ho, PhD, D(ABHI), FAACC, HLA Lab Director, Gift of Hope Organ & Tissue Donor Network, USA
Let's Get Started On Your Story- Testimonial
- Transplant
- Customer
I really appreciate Immucor's continuous interest in listening to the customer. That is what makes Immucor a great partner to our labs. I know that our needs and ideas will be heard and taken into consideration to improve the products. That makes a world of difference to us in the labs and is truly appreciated.
Valia Bravo-Egana, PhD, F(ACHI), MBA, Director, Technical Supervisor and Clinical Consultant, Histocompatibility/Immunology Laboratory, Medical College of Georgia, USA
Let's Get Started On Your StoryUpcoming Events,
Webinars & Workshops
Keep Up With Us
News & Blogs
Werfen acquires Omixon
Werfen has completed the acquisition of Omixon, a privately held company based in Budapest, Hungary, focused on the development and commercialization of Next Generation Sequencing (NGS) technologies in transplant diagnostics. The acquisition expands Werfen’s portfolio of transplant diagnostics solutions for...
News & Blogs
MIA FORATM NGS EXPRESS HLA Typing Software: You Spoke, We Listened!
Introducing MIA FORA NGS EXPRESS HLA Typing Software, Immucor’s next step in providing value-added user...
News & Blogs
Coming Soon: Detect DP with LIFECODES® LifeScreen Deluxe!
Immucor is in the process of improving our LIFECODES® LifeScreen Deluxe (LMX) to add DP...
News & Blogs
CUSTOMER SPOTLIGHT: Mid-South Transplant Foundation, Inc. C3d Validation and Implementation
For all histocompatibility laboratories, Complement-Dependent Cytotoxicity (CDC) testing proves to be time consuming and tedious...
News & Blogs
CUSTOMER SPOTLIGHT: Northwestern University Transplant Immunology Laboratory
Bridging the Gap: Implementing Multiple Single Antigen Vendors to Ensure Confidence in Results. More labs...
Experience Our Virtual Lab
Contact your sales representative for a personal tour.
